| Preoperative parameters |
Sufentanil |
Remifentanil |
p-value |
| Number of patients |
14 |
14 |
|
| Age (years ± SD) |
69.5 ± 6.4 |
70.5 ± 5.7 |
0.667!) |
| Height (cm ± SD) |
173.7 ± 9.0 |
171.3 ± 7.3 |
0.439!) |
| Weight (kg ± SD) |
83.3 ± 15.6 |
79.4 ± 15.8 |
0.551!) |
| BMI (kg m-2 ± SD) |
27.5 ± 3.9 |
26.1 ± 4.4 |
0.386!) |
| Type of surgery (CABG/CABG+AVR) |
10 (71.5)/4 (28.6) |
8 (57.1)/6 (42.9) |
0.693¤) |
| EuroSCORE I (median (IQR)) |
4 (2-6) |
4 (4-4) |
0.869§) |
| s-Creatininemmol/L (median(IQR)) |
84 (80-97) |
79 (74-83) |
0.085§) |
| No of scheduled grafts (median(IQR)) |
2 (1-2) |
2 (2-3) |
0.217§) |
| Female (n (%)) |
5 (35.7) |
3 (21.4) |
0.676¤) |
| Beta-blockers (n (%)) |
9 (64.0) |
7 (50.0) |
0.703¤) |
| Ca-antagonists (n (%)) |
5 (35.7) |
3 (21.4) |
0.676¤) |
| Ace-inhibitors (n (%)) |
2 (14.3) |
6 (42.9) |
0.210¤) |
| GLPS (%)(mean ± SD) |
-14.0 ± 2.7 |
-14.9 ± 4.1 |
0.528!) |
| E/e' ratio (mean ± SD) |
9.38 ± 5.53 |
9.58 ± 3.41 |
0.907!) |
| E’/a’ ratio (mean ± SD) |
0.84 ± 0.14 |
0.83 ± 0.28 |
0.960!) |
|
